Based in Lyon with a team of 25 people, Brenus Pharma is a French clinical-stage biotech company developing next-generation in vivo immunotherapies targeting solid tumors, which are responsible for most therapeutic failures in oncology. Our mission is to provide an effective treatment option for patients who have no alternative to chemotherapy.
Our proprietary technology is designed to mimic cancer biology and educate the patient’s immune system to recognize and eliminate malignant cells. Our lead candidate, STC‑1010, targets microsatellite‑stable (MSS) colorectal cancer, a form that responds poorly to current immunotherapies, and entered a Phase I/IIa clinical trial in 2025. We are supported by leading worldwide investors and public stakeholders (Bpifrance, France2030, etc.).
We are looking for an immuno-oncology scientist with strong biological expertise and the ability to analyze and interpret complex molecular data. The position is computational and does not include routine laboratory work.
The R&D Project Manager will support Brenus Pharma’s preclinical and translational/innovation research programs by analyzing and interpreting biological data. The successful candidate will work at the interface between immunology, oncology and bioinformatics. This positionis intended for a scientist with a strong understanding of cancer immunology who is also comfortable working with sequencing and multi-omics data
For any information : careers@brenus-pharma.com
By joining the team, you become part of a company where science, people and purpose move forward together. At Brenus, our culture is built on curiosity, learning, and the desire to grow,both individually and collectively. We value creativity, open‑mindedness, teamwork, and the joy of sharing ideas, challenges, and new experiences. Collaboration, mutual support, and finding solutions together are at the heart of how we work every day. Beyond our projects, we aim to have a positive impact in healthcare: advancing scientific innovation by improving patients’ lives.

